Trial
NCT04128371
Mepolizumab in Episodic Angioedema With Eosinophilia
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
—
Condition
Eosinophilia
Intervention
mepolizumab
Why stopped
Study was closed after the first five participants completed their participation due to lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-16